Bartsch, Rupert http://orcid.org/0000-0002-4384-6917
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 17 April 2021
Accepted: 26 May 2021
First Online: 29 June 2021
Conflict of interest
: R. Bartsch: Advisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen; Lecture Honoraria: Astra-Zeneca, Celgene, Eli-Lilly, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen; Research Support: Daiichi, MSD, Novartis, Roche.